Funding with Alternative Capital Sources

Description

Securing funding remains a critical challenge for emerging companies, particularly in the biotech, medical device, and surgical instrumentation sectors. While traditional capital sources—angel investors, family offices, high-net-worth individuals, and venture capital—each come with their strategies and nuances, a wide range of alternative funding options have emerged over the past five decades. 

This program will explore these often overlooked or misunderstood sources of capital, including non-dilutive funding such as federal and state grants, venture studios and foundries, strategic partnerships, and other creative financing mechanisms. 

Join us for a dynamic discussion covering: 

• The evolving landscape of non-traditional funding Strategic Partnerships with Big Pharma 
• The role and impact of incubators, accelerators, and nonprofits 
• Key policy considerations under the current administration 

Come hear from seasoned experts as they share strategies and critical insights for securing non-dilutive funding—essential tools for emerging companies striving to survive, compete, and grow in today’s challenging landscape of tightening capital. 

Our panel features Jon Weaver, CEO of Mass Biomedical Initiative; Gary Magnant, founder of Formation Venture Engineering, a venture foundry; Julie Fife, Managing Partner at DeBusk & Fife and a leading authority on government grant funding; and Imran Nasrullah, Chief Business Officer of Grove Biopharmaceuticals and former U.S. Head of BD&L/Open Innovation at Bayer AG, as well as U.S. Search & Evaluation at Boehringer-Ingelheim.

The discussion will be moderated by John Hession, a veteran emerging company attorney, longtime angel investor, and recent member of the Investment Advisory Committee for Hub Angels VII. 

Following the panel, join us for a lively, moderated Q&A session, where your questions and insights will enrich the conversation. Gain actionable insights into how early-stage life sciences companies can diversify their funding strategies and strengthen their position for long-term success.

REGISTER HERE